Switch to: References

Add citations

You must login to add citations.
  1. Patient-specific devices and population-level evidence: evaluating therapeutic interventions with inherent variation.Mary Jean Walker - 2018 - Medicine, Health Care and Philosophy 21 (3):335-345.
    Designing and manufacturing medical devices for specific patients is becoming increasingly feasible with developments in 3D printing and 3D imaging software. This raises the question of how patient-specific devices can be evaluated, since our ‘gold standard’ method for evaluation, the randomised controlled trial, requires that an intervention is standardised across a number of individuals in an experimental group. I distinguish several senses of patient-specific device, and focus the discussion on understanding the problem of variations between instances of an intervention for (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Notes on the use of randomised controlled trials to evaluate complex interventions: Community treatment orders as an illustrative case.Feras Ali Mustafa - 2017 - Journal of Evaluation in Clinical Practice 23 (1):185-192.
    Over the past seven decades, randomised controlled trials (RCTs) have revolutionised clinical research and achieved a gold standard status. However, extending their use to evaluate complex interventions is problematic. In this paper we will demonstrate that complex intervention RCTs violate the necessary premises that govern the RCTs logic and underpin their rigour. The lack of blinding, heterogeneity of participants, as well as poor treatment standardisation and difficulty of controlling for confounders, which characterise complex intervention RCTs, can potentially be profoundly detrimental (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations